NEVVI Medicare utilization intelligence
or

← back

Provider profile

HEAVEN, RALPH M.D.

Hematology-Oncology · NPI 1023056280 · ABILENE, TX

1
Groups
55
Codes · 2024
86,022
Disclosed services

HEAVEN, RALPH is a Hematology-Oncology in ABILENE, TX, a member of 1 medical group, who billed 55 distinct codes to Medicare Part B in 2024.

Groups: TEXAS ONCOLOGY PA (DALLAS, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

86,022
disclosed services
55
codes billed to Medicare Part B
Prior year · CY2023 88,761 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J9271 Injection, pembrolizumab, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
J1626 Injection, granisetron hydrochloride, 100 mcg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
83615 Lactate dehydrogenase (enzyme) level
96413 Administration of chemotherapy into vein, 1 hour or less
96372 Injection of drug or substance under skin or into muscle
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
82378 Carcinoembryonic antigen (cea) protein level
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96375 Injection of additional new drug or substance into vein
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
83735 Magnesium level
84153 Psa (prostate specific antigen) measurement, total
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
85055 Reticulated (young) platelet measurement
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
96523 Irrigation of implanted venous access drug delivery device
J7030 Infusion, normal saline solution , 1000 cc
71260 Ct scan of chest with contrast
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
96417 Administration of additional new drug or substance into vein, 1 hour or less
74177 Ct scan of abdomen and pelvis with contrast
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
J1200 Injection, diphenhydramine hcl, up to 50 mg
96360 Infusion into a vein for hydration, 31-60 minutes
96415 Administration of chemotherapy into vein, each additional hour
81002 Urinalysis, manual test
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
99195 Drawing of blood for a medical problem
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
J3490 Unclassified drugs
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
96361 Infusion into a vein for hydration, each additional hour

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.